Key result
This article discusses the RATPAC study evaluating whether a point-of-care panel of myoglobin, CKMB, and sensitive troponin is superior to troponin alone for diagnosing acute myocardial infarction.
Why the study?
Does a point-of-care biomarker panel (myoglobin, CKMB, and sensitive troponin) improve diagnostic efficiency compared to troponin alone for the early diagnosis of myocardial infarction in patients with chest pain?
Population
Patients presenting with chest pain in the emergency setting
Comparison
Point-of-care testing panel combining myoglobin… vs Troponin measurement alone
Design
Editorial
Authors
Loading...
This article evaluates whether a multi-biomarker point-of-care panel offers superior diagnostic efficiency over troponin alone for rapid diagnosis of acute myocardial infarction.
Does a point-of-care biomarker panel (myoglobin, CKMB, and sensitive troponin) improve diagnostic efficiency compared to troponin alone for the early diagnosis of myocardial infarction in patients with chest pain?
This article evaluates whether a multi-biomarker point-of-care panel offers superior diagnostic efficiency over troponin alone for rapid diagnosis of acute myocardial infarction.
Kavsak et al. (2012) conducted a review in acute myocardial infarction. Point-of-care panel of myoglobin, CKMB, and sensitive troponin vs. Troponin alone was evaluated. This article discusses the RATPAC study evaluating whether a point-of-care panel of myoglobin, CKMB, and sensitive troponin is superior to troponin alone for diagnosing acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: